(-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
暂无分享,去创建一个
Herbert Waldmann | Tobias Seitz | David J Beech | Slava Ziegler | Mathias Christmann | H. Waldmann | N. Vasudev | Tobias Seitz | K. Muraki | Slava Ziegler | M. Christmann | M. Amer | Hannah J Gaunt | Mohamed S Amer | Melanie J Ludlow | Katsuhiko Muraki | A. Bruns | Naveen S Vasudev | D. Beech | M. J. Ludlow | Matthieu Willot | Lea Radtke | Yasemin Akbulut | Alexander Bruns | Sven Hahn | M. Willot | Sven Hahn | Lea Radtke | Yasemin Akbulut | H. Gaunt
[1] V. Haase,et al. Renal cancer: oxygen meets metabolism. , 2012, Experimental cell research.
[2] B. Nilius,et al. TRPs in Our Senses , 2008, Current Biology.
[3] P. Metz,et al. A short enantioselective total synthesis of (-)-englerin A. , 2013, Angewandte Chemie.
[4] Herbert Waldmann,et al. Biology-oriented synthesis: harnessing the power of evolution. , 2014, Journal of the American Chemical Society.
[5] Carsten Strohmann,et al. Total synthesis and absolute configuration of the guaiane sesquiterpene englerin A. , 2009, Angewandte Chemie.
[6] David J Beech,et al. Characteristics of transient receptor potential canonical calcium-permeable channels and their relevance to vascular physiology and disease. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[7] W. Linehan,et al. Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. , 2013, Cancer cell.
[8] R. Williams,et al. Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy , 2013, Journal of experimental & clinical cancer research : CR.
[9] William J. Chain,et al. A brief synthesis of (-)-englerin A. , 2011, Journal of the American Chemical Society.
[10] J. Ramos,et al. Englerin A Selectively Induces Necrosis in Human Renal Cancer Cells , 2012, PloS one.
[11] F. Koehn,et al. The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.
[12] P. Emery,et al. TRPC channel activation by extracellular thioredoxin , 2008, Nature.
[13] K. Gustafson,et al. Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri. , 2009, Organic letters.
[14] K. Nicolaou,et al. Total synthesis of englerin A. , 2010, Journal of the American Chemical Society.
[15] S. Danishefsky,et al. Small molecule natural products in the discovery of therapeutic agents: the synthesis connection. , 2006, The Journal of organic chemistry.
[16] T. Bíró,et al. Transient receptor potential channels as therapeutic targets , 2011, Nature Reviews Drug Discovery.
[17] S. Wetzel,et al. Biologie‐orientierte Synthese (BIOS) , 2011 .
[18] Cheng Zhang,et al. Nature's contribution to today's pharmacopeia , 2014, Nature Biotechnology.
[19] David J Newman,et al. Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.
[20] P. Esper. Concepts in advanced renal carcinoma. , 2012, Seminars in oncology nursing.
[21] C. Tseng,et al. Chemical synthesis of the englerins. , 2012, Chemistry, an Asian journal.
[22] D. Clapham,et al. TRPC1 and TRPC5 Form a Novel Cation Channel in Mammalian Brain , 2001, Neuron.
[23] Stefan Wetzel,et al. Biology-oriented synthesis. , 2011, Angewandte Chemie.
[24] David J Beech,et al. In pursuit of small molecule chemistry for calcium‐permeable non‐selective TRPC channels – mirage or pot of gold? , 2013, British journal of pharmacology.
[25] P. Metz,et al. Eine kurze enantioselektive Totalsynthese von (−)‐Englerin A , 2013 .
[26] L. Birnbaumer,et al. Physiology and pathophysiology of canonical transient receptor potential channels , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Herbert Waldmann,et al. Bioactivity-guided navigation of chemical space. , 2010, Accounts of chemical research.
[28] Rosamonde E Banks,et al. Renal cancer biomarkers: the promise of personalized care , 2012, BMC Medicine.
[29] Jing Xu,et al. Enantioselective formal synthesis of (-)-englerin A via a Rh-catalyzed [4 + 3] cycloaddition reaction. , 2010, Organic letters.
[30] A. Beck,et al. Conserved Gating Elements in TRPC4 and TRPC5 Channels* , 2013, The Journal of Biological Chemistry.
[31] N. Smith,et al. Transient potential receptor channel 4 controls thrombospondin‐1 secretion and angiogenesis in renal cell carcinoma , 2007, The FEBS journal.
[32] Qianghui Zhou,et al. Asymmetric, protecting-group-free total synthesis of (-)-englerin A. , 2010, Angewandte Chemie.
[33] S. Wetzel,et al. Biology-inspired synthesis of compound libraries , 2008, Cellular and Molecular Life Sciences.
[34] Melissa R. Miller,et al. Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels* , 2011, The Journal of Biological Chemistry.
[35] R. Fröhlich,et al. Totalsynthese und absolute Konfiguration des Guaian-Sesquiterpens Englerin A† , 2009 .
[36] L. Kiemeney,et al. Corrigendum to "The Epidemiology of Renal Cell Carcinoma" [Eur Urol 2011;60:615-21]. , 2011, European urology.
[37] I. So,et al. Isoform- and receptor-specific channel property of canonical transient receptor potential (TRPC)1/4 channels , 2013, Pflügers Archiv - European Journal of Physiology.
[38] T. Gudermann,et al. Receptor-mediated Regulation of the Nonselective Cation Channels TRPC4 and TRPC5* , 2000, The Journal of Biological Chemistry.
[39] R. Fröhlich,et al. Total synthesis and biological evaluation of (-)-englerin A and B: synthesis of analogues with improved activity profile. , 2011, Angewandte Chemie.
[40] Kian Molawi,et al. Enantioselective synthesis of (-)-englerins A and B. , 2010, Angewandte Chemie.